GZMA and hepatocellular carcinoma: Nevertheless, we found that HCC patients with a high potential neoepitope, coupled with a favorable tumor microenvironment, as assessed by high expression of GZMA, low expression of FoxP3 and PDL1, tended to have a prolonged survival.